Generic Zomig

There are currently no generic versions of Zomig tablets, Zomig Nasal Spray, or Zomig ZMT tablets because these products are protected by patents. The earliest date that you might be able to find an approved generic Zomig, generic Zomig ZMT, or generic Zomig Nasal Spay is 2013, when the patents for these products expire. Until then, you should not buy any products sold as "generic" versions of Zomig.

Generic Zomig: An Overview

Zomig® (zolmitriptan) is a prescription medication that is used to treat migraine headaches. Zomig will not help to prevent migraines, but it can help to treat a migraine that has already started. In addition to Zomig tablets, Zomig® Nasal Spray and Zomig ZMT® (orally disintegrating tablets that dissolve in the mouth) are also available.
 
Zomig tablets, Zomig ZMT, and Zomig Nasal Spray are manufactured by AstraZeneca Pharmaceuticals. They are currently under the protection of a patent that prevents any generic Zomig from being manufactured in the United States.
 
Yet, if you search the Internet for "generic Zomig," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic Zomig available from another country, but there is really no way of knowing whether or not you are getting genuine Zomig. You should not buy any generic Zomig until there is an approved generic available.
 

When Will the Zomig Patent Expire?

The first patents for Zomig currently expire in 2013. This is the earliest date that you might be able to find an approved generic Zomig, generic Zomig ZMT, or generic Zomig Nasal Spay. However, there are other circumstances that could come up to extend the exclusivity period of Zomig beyond 2013. These circumstances could include things such as other patents for specific Zomig uses or lawsuits. Once Zomig goes off patent, there may be several companies that manufacture a generic Zomig drug.
 
(Generic Zomig Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation